Specifications
Immunogen
Synthetic peptide (the amino acid sequence is considered to be commercially sensitive) within Human NAD Synthetase aa 650 to the C-terminus (Cysteine residue). The exact sequence is proprietary.Database link: Q6IA69
Applications
Application Notes
WB: 1/1000 - 1/5000; IHC-P: 1/50 - 1/100; ICC/IF: 1/50 - 1/100; Flow Cyt: 1/100 - 1/500;
Target
Alternative Names
NADSYN1; NAD synthetase 1; glutamine-dependent NAD(+) synthetase; FLJ10631; NAD(+) synthase; NAD(+) synthetase; glutamine-dependent NAD synthetase; FLJ36703; FLJ40627;
Product Background
Antigen Description
Nicotinamide adenine dinucleotide (NAD) is a coenzyme in metabolic redox reactions, a precursor for several cell signaling molecules, and a substrate for protein posttranslational modifications. NAD synthetase catalyzes the final step in the biosynthesis of NAD from nicotinic acid adenine dinucleotide (NaAD)
Pathway
Metabolic pathways, organism-specific biosystem; Metabolism, organism-specific biosystem; Metabolism of vitamins and cofactors, organism-specific biosystem; Metabolism of water-soluble vitamins and cofactors, organism-specific biosystem; NAD biosynthesis II (from tryptophan), organism-specific biosystem; NAD biosynthesis from 2-amino-3-carboxymuconate semialdehyde, organism-specific biosystem; Nicotinate and nicotinamide metabolism, organism-specific biosystem;
Citations
Publication ()
Have you cited DCABH-5709 in a publication?
Let us know and earn a reward for your research.